Pediatric Puzzler: Status epilepticus in a preadolescent: A ball of twine unravels

This decision marks the second time the FDA has issued a complete response letter (CRL) for dasiglucagon to treat hypoglycemia in patients 7 days and up with congenital hyperinsulinism.

While rates of exclusive breastfeeding have slightly increased between 2016 and 2022, they remain under the Healthy People 2030 goal.

In this article, Colleen Sloan explores key nutrition strategies that pediatricians can confidently share with families to help their young athletes perform at their best.

This week, take a look at several video interviews with experts from the 2024 AAP meetings, all in one place.